Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?

被引：3
|
作者：
Beatrice Macchi
Antonio Mastino
机构：
[1] Department of Systems Medicine, University of Rome "Tor Vergata"
[2] Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina
[3] The Institute of Translational Pharmacology,CNR
来源：
NeuralRegenerationResearch | 2016年 / 11卷 / 05期
关键词：
new potential therapeutic targets; cell; MS;
D O I：
暂无
中图分类号：
R744.51 [];
学科分类号：
1002 ;
摘要：
Multiple sclerosis(MS)is a chronic,severe and complex disease of still uncertain etiopathogenesis,with lesions in the cerebral white matter and spinal cord.The disease is heterogeneous,but is characterized by neuroinflammatory and neurodegenerative processes,usually associated with altered activation of the immune system following presumable stimulation by still unknown autoantigens.Several data confirm that
引用
收藏
页码：733 / 734
页数：2
相关论文
共 50 条
  • [21] A role for natural killer cells in the immunopathogenesis of multiple sclerosis
    Kastrukoff, LF
    Morgan, NG
    Zecchini, D
    White, R
    Petkau, AJ
    Satoh, JI
    Paty, DW
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 86 (02) : 123 - 133
  • [22] Natural killer cells as indispensable players and therapeutic targets in autoimmunity
    Shi, Fu-Dong
    Zhou, Qinghua
    AUTOIMMUNITY, 2011, 44 (01) : 3 - 10
  • [23] Natural killer cells are functionally defective in multiple sclerosis
    Laroni, A.
    Armentani, E.
    Gandhi, R.
    Gandoglia, I.
    Ivaldi, F.
    de Rosbo, N. Kerlero
    Mancardi, G.
    Weiner, H.
    Uccelli, A.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 145 - 146
  • [24] Nonfunctional natural killer regulatory cells in multiple sclerosis
    Laroni, A.
    Armentani, E.
    de Rosbo, N. Kerlero
    Ivaldi, F.
    Marcenaro, E.
    Sivori, S.
    Gandhi, R.
    Weiner, H. L.
    Moretta, A.
    Mancardi, G. L.
    Uccelli, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 157 - 158
  • [25] Regulatory Functions of Natural Killer Cells in Multiple Sclerosis
    Gross, Catharina C.
    Schulte-Mecklenbeck, Andreas
    Wiendl, Heinz
    Marcenaro, Emanuela
    de Rosbo, Nicole Kerlero
    Uccelli, Antonio
    Laroni, Alice
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [26] The role of Natural Killer cells in Multiple Sclerosis pathogenesis
    Tahrali, I.
    Kucuksezer, U. C.
    Yilmaz, A.
    Uygunoglu, U.
    Altintas, A.
    Deniz, G.
    IMMUNOLOGY, 2012, 137 : 244 - 244
  • [27] Inhibition of programmed cell death by melanoma cell subpopulations reveals mechanisms of melanoma metastasis and potential therapeutic targets
    An, Yuepeng
    Zhao, Fu
    Jia, Hongling
    Meng, Siyu
    Zhang, Ziwei
    Li, Shuxiao
    Zhao, Jiusi
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [28] PROGRAMMED CELL-DEATH IN MULTIPLE-SCLEROSIS BRAIN
    DOWLING, PC
    BANSIL, S
    MENONNA, J
    HUSAR, W
    COOK, SD
    ANNALS OF NEUROLOGY, 1995, 38 (02) : 341 - 341
  • [29] Glial cells as therapeutic targets in progressive multiple sclerosis
    Wilbanks, Brandon
    Maher, L. J., III
    Rodriguez, Moses
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (06) : 481 - 494
  • [30] Programmed Cell Death of Endothelial Cells in Myocardial Infarction and Its Potential Therapeutic Strategy
    Wu, Mingyue
    Huang, Zixia
    Zeng, Lijin
    Wang, Chunfei
    Wang, Deming
    CARDIOLOGY RESEARCH AND PRACTICE, 2022, 2022
12345